-
Vaccine for Parkinson's Reports Positive Results from Boost Study
September 7, 2016
… a vaccine (called PD01A) to cause the body’s immune system to create antibodies against alpha-synuclein, … because the treatment is relying on each person’s immune system to create the antibodies and we just don’t know …
-
Latest Trials against Top Parkinson's Protein Alpha-synuclein
July 17, 2018
… after alpha-synuclein is with antibodies: the body’s immune system fighters. Biotechnology company Prothena is … for the trial team. Harnessing the Power of the Immune System to Protect Cells Austrian biotech AFFiRiS found its …
-
Resources for Parkinson's Researchers
… Parkinson's Disease is Moving Towards a Biologic Staging System Recent biomarker advancements enable accurate … clinical symptoms. This proposal introduces a staging system, NSD-ISS, categorizing individuals by α-synuclein …
-
MJFF Resources for Parkinson’s Research
… Parkinson's Disease is Moving Towards a Biologic Staging System Recent biomarker advancements enable accurate … symptoms. This proposal introduces an integrated staging system, NSD-ISS, categorizing individuals by α-synuclein …
-
Michael J. Fox Foundation Commits up to $2 Million to Address "Critical Challenges" in PD
May 24, 2007
… and pathology. “LRRK2 and alpha-synuclein are only two of multiple therapeutic targets that researchers have …
-
Sixteen International Parkinson's Disease Organizations Join Forces to Raise Global Awareness for Clinical Trial Participation
April 11, 2013
… family member and friend.” Steve has participated in multiple trials and arranges rides for other trial …